Evidence map›Paper›PMID 18323469›Full record

ArticleMolecular endocrinology (Baltimore, Md.)2008

Liver receptor homolog-1 regulates bile acid homeostasis but is not essential for feedback regulation of bile acid synthesis.

Youn-Kyoung Lee, Daniel R Schmidt, Carolyn L Cummins, Mihwa Choi, Li Peng, Yuan Zhang, Bryan Goodwin, Robert E Hammer, David J Mangelsdorf, Steven A Kliewer

Abstract read
In one paragraph

Article in Molecular endocrinology (Baltimore, Md.), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 153 citations in OpenAlex.

  1. Review
  2. Article
  3. Differential Expression Characteristics of Two IsoformsAnimals : an open access journal from MDPI · 2025
    Article
  4. Article
  5. Fragment-Based Discovery of Drug-like LRH-1 Agonists.ACS medicinal chemistry letters · 2025
    Article
  6. Fatty Acid Mimetic Fragments as Liver Receptor Homologue-1 Modulators.ACS pharmacology & translational science · 2025
    Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Youn-Kyoung LeeDepartment of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9041, USA.
Daniel R Schmidt
Carolyn L Cummins
Mihwa Choi
Li Peng
Yuan Zhang
Bryan Goodwin
Robert E Hammer
David J Mangelsdorf
Steven A Kliewer
Dallas Nephrology Associates · USGlaxoSmithKline (United States) · USSouthwestern Medical Center · US

Funding

Tissue-specific Mechanism of Action of the Metabolic Hormones FGF19 and FGF21R01DK067158 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI KLIEWER, STEVEN A. · 2004 to 2017
$4.1M
Howard Hughes Medical InstituteNIDDK NIH HHS DK067158NIDDK NIH HHS R01 DK067158
6 · The paper itself

Abstract

Liver receptor homolog 1 (LRH-1), an orphan nuclear receptor, is highly expressed in liver and intestine, where it is implicated in the regulation of cholesterol, bile acid, and steroid hormone homeostasis. Among the proposed LRH-1 target genes in liver are those encoding cholesterol 7alpha-hydroxylase (CYP7A1) and sterol 12alpha-hydroxylase (CYP8B1), which catalyze key steps in bile acid synthesis. In vitro studies suggest that LRH-1 may be involved both in stimulating basal CYP7A1 and CYP8B1 transcription and in repressing their expression as part of the nuclear bile acid receptor [farnesoid X receptor (FXR)]-small heterodimer partner signaling cascade, which culminates in small heterodimer partner binding to LRH-1 to repress gene transcription. However, in vivo analysis of LRH-1 actions has been hampered by the embryonic lethality of Lrh-1 knockout mice. To overcome this obstacle, mice were generated in which Lrh-1 was selectively disrupted in either hepatocytes or intestinal epithelium. LRH-1 deficiency in either tissue changed mRNA levels of genes involved in cholesterol and bile acid homeostasis. Surprisingly, LRH-1 deficiency in hepatocytes had no significant effect on basal Cyp7a1 expression or its repression by FXR. Whereas Cyp8b1 repression by FXR was also intact in mice deficient for LRH-1 in hepatocytes, basal CYP8B1 mRNA levels were significantly decreased, and there were corresponding changes in the composition of the bile acid pool. Taken together, these data reveal a broad role for LRH-1 in regulating bile acid homeostasis but demonstrate that LRH-1 is either not involved in the feedback regulation of bile acid synthesis or is compensated for by other factors.

Indexed as

AnimalsBile Acids and SaltsCells, CulturedCloning, MolecularDNA-Binding ProteinsFeedback, PhysiologicalHepatocytesHomeostasisIntestinal MucosaMiceMice, KnockoutOrgan SpecificityReceptor, Farnesoid X-ActivatedReceptors, Cytoplasmic and NuclearTranscriptional ActivationTranscription FactorsBile Acids and SaltsDNA-Binding ProteinsNr5a2 protein, mouseReceptor, Farnesoid X-ActivatedReceptors, Cytoplasmic and NuclearTranscription Factors

Identifiers

PMID18323469
PMCPMC2409274
OpenAlexW1979510879

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.